tiprankstipranks
Seaport Therapeutics, Inc. (SPTX)
NASDAQ:SPTX
US Market
SPTX
Seaport Therapeutics, Inc.
RESEARCH TOOLSreports

Seaport Therapeutics, Inc. (SPTX) Stock Forecast & Price Target

17 Followers
See the Price Targets and Ratings of:

SPTX Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Seaport
Therapeutics, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SPTX Stock 12 Month Forecast

Average Price Target

$38.40
▲(57.96% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Seaport Therapeutics, Inc. in the last 3 months. The average price target is $38.40 with a high forecast of $50.00 and a low forecast of $30.00. The average price target represents a 57.96% change from the last price of $24.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","51":"$51","24.75":"$24.8","33.5":"$33.5","42.25":"$42.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$38.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,24.75,33.5,42.25,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.46,22.732307692307693,25.004615384615384,27.276923076923076,29.549230769230768,31.82153846153846,34.09384615384616,36.36615384615385,38.63846153846154,40.91076923076923,43.183076923076925,45.45538461538462,47.72769230769231,{"y":50,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.46,21.84,23.22,24.6,25.98,27.36,28.740000000000002,30.12,31.5,32.879999999999995,34.26,35.64,37.019999999999996,{"y":38.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.46,21.193846153846156,21.927692307692308,22.661538461538463,23.395384615384614,24.12923076923077,24.863076923076925,25.596923076923076,26.33076923076923,27.064615384615387,27.798461538461538,28.532307692307693,29.26615384615385,{"y":30,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.84,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.13,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.45,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.46,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$50.00Average Price Target$38.40Lowest Price Target$30.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SPTX
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$50
Buy
105.68%
Upside
Reiterated
08/21/26
Selvaraju Reiterates Buy on Seaport, Citing Differentiated Neuropsychiatry Pipeline and Unchanged $50 Price Target
Stifel Nicolaus Analyst forecast on SPTX
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$30
Buy
23.41%
Upside
Reiterated
08/13/26
Seaport Therapeutics, Inc. (SPTX) Gets a Buy from Stifel Nicolaus
Citi Analyst forecast on SPTX
Yigal Nochomovitz
Citi
Citi
$35
Buy
43.97%
Upside
Reiterated
08/03/26
Analysts' Top NA Picks: Ceribell, Inc. (CBLL), Ethos Technologies Inc. Class A (LIFE)
Wolfe Research Analyst forecast on SPTX
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
07/07/26
Seaport Therapeutics initiated with a Peer Perform at Wolfe ResearchSeaport Therapeutics initiated with a Peer Perform at Wolfe Research
J.P. Morgan Analyst forecast on SPTX
Tessa Romero
J.P. Morgan
J.P. Morgan
$42
Buy
72.77%
Upside
Reiterated
06/08/26
Seaport Therapeutics: Buy Rating Reiterated on Advancing CNS Pipeline and Strong Cash Runway; $42 Price Target Unchanged
Leerink Partners Analyst forecast on SPTX
Marc Goodman
Leerink Partners
Leerink Partners
$35
Buy
43.97%
Upside
Initiated
05/27/26
Seaport Therapeutics initiated with an Outperform at LeerinkSeaport Therapeutics initiated with an Outperform at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SPTX
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$50
Buy
105.68%
Upside
Reiterated
08/21/26
Selvaraju Reiterates Buy on Seaport, Citing Differentiated Neuropsychiatry Pipeline and Unchanged $50 Price Target
Stifel Nicolaus Analyst forecast on SPTX
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$30
Buy
23.41%
Upside
Reiterated
08/13/26
Seaport Therapeutics, Inc. (SPTX) Gets a Buy from Stifel Nicolaus
Citi Analyst forecast on SPTX
Yigal Nochomovitz
Citi
Citi
$35
Buy
43.97%
Upside
Reiterated
08/03/26
Analysts' Top NA Picks: Ceribell, Inc. (CBLL), Ethos Technologies Inc. Class A (LIFE)
Wolfe Research Analyst forecast on SPTX
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
07/07/26
Seaport Therapeutics initiated with a Peer Perform at Wolfe ResearchSeaport Therapeutics initiated with a Peer Perform at Wolfe Research
J.P. Morgan Analyst forecast on SPTX
Tessa Romero
J.P. Morgan
J.P. Morgan
$42
Buy
72.77%
Upside
Reiterated
06/08/26
Seaport Therapeutics: Buy Rating Reiterated on Advancing CNS Pipeline and Strong Cash Runway; $42 Price Target Unchanged
Leerink Partners Analyst forecast on SPTX
Marc Goodman
Leerink Partners
Leerink Partners
$35
Buy
43.97%
Upside
Initiated
05/27/26
Seaport Therapeutics initiated with an Outperform at LeerinkSeaport Therapeutics initiated with an Outperform at Leerink
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Seaport Therapeutics, Inc.

3 Months
Yigal NochomovitzCiti
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.70%
Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.70% per trade.
1 Year
Yigal NochomovitzCiti
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.70%
Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.70% per trade.
2 Years
Yigal NochomovitzCiti
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.70%
Copying Yigal Nochomovitz's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -7.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SPTX Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
4
8
9
8
Buy
0
0
0
0
1
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
4
8
10
10
In the current month, SPTX has received 9 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SPTX average Analyst price target in the past 3 months is 38.40.
Each month's total comprises the sum of three months' worth of ratings.

SPTX Financial Forecast

SPTX Earnings Forecast

Next quarter’s earnings estimate for SPTX is -$0.62 with a range of -$0.96 to -$0.48. The previous quarter’s EPS was -$10.34. SPTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SPTX has its overall industry.
Next quarter’s earnings estimate for SPTX is -$0.62 with a range of -$0.96 to -$0.48. The previous quarter’s EPS was -$10.34. SPTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SPTX has its overall industry.
No data currently available

SPTX Sales Forecast

Next quarter’s sales forecast for SPTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SPTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SPTX has its overall industry.
Next quarter’s sales forecast for SPTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SPTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SPTX has its overall industry.

SPTX Stock Forecast FAQ

What is SPTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Seaport Therapeutics, Inc.’s 12-month average price target is 38.40.
    What is SPTX’s upside potential, based on the analysts’ average price target?
    Seaport Therapeutics, Inc. has 57.96% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SPTX a Buy, Sell or Hold?
          Seaport Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Seaport Therapeutics, Inc.’s price target?
            The average price target for Seaport Therapeutics, Inc. is 38.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $50.00 ,the lowest forecast is $30.00. The average price target represents 57.96% Increase from the current price of $24.31.
              What do analysts say about Seaport Therapeutics, Inc.?
              Seaport Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of SPTX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.